CervoMed presents neflamapimod trial data
CervoMed (NASDAQ:CRVO) announced that neflamapimod will be featured in a late-breaking oral presentation at the International Society of Frontotemporal Dementias Annual Meeting in October 2026.
CervoMed (NASDAQ:CRVO) announced that neflamapimod will be featured in a late-breaking oral presentation at the International Society of Frontotemporal Dementias Annual Meeting in October 2026.
MasterCraft Boat Holdings (NASDAQ:MCFT) reported fiscal fourth-quarter 2026 net sales of $129.9 million, up $50.4 million or 63.4% year over year.
Burning Rock Biotech (NASDAQ:BNR) reported second-quarter 2026 revenue of RMB134.7 million, down 9.3% year over year, with net loss increasing to RMB18.4 million.
The Lovesac Company (NASDAQ:LOVE) reported second-quarter fiscal 2027 net sales of $161.2 million, up 0.4% year over year, and returned to quarterly profitability with net income of $7.4 million.
Vince Holding (NASDAQ:VNCE) reported second-quarter 2026 net sales of $81.8 million, up 11.7% from $73.2 million in the prior-year period, driven by growth in direct-to-consumer and wholesale channels.
Macy’s (NYSE:M) reported second-quarter 2026 net sales of $4.9 billion, up 1.1% year over year, and raised its annual guidance.
1-800-FLOWERS.COM (NASDAQ:FLWS) reported fiscal fourth-quarter 2026 revenue of $293.1 million, down 12.9% year over year, with a net loss of $52.3 million.
Chemours (NYSE:CC), DuPont, and Corteva agreed to a $455 million settlement with North Carolina and 11 local entities to resolve PFAS-related litigation and historical discharge claims.
Designer Brands (NYSE:DBI) reported second-quarter 2026 net sales of $730.6 million, down 1.2% year over year, while net income increased to $17.6 million.
Taiwan Semiconductor Manufacturing Company (NYSE:TSM) reported August 2026 consolidated revenue of approximately NT$514.81 billion, representing a 53.3% increase from August 2025.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy